Dexmedetomidine and Long-term Outcomes in Elderly Patients After Cardiac Surgery

NACompletedINTERVENTIONAL
Enrollment

285

Participants

Timeline

Start Date

October 21, 2021

Primary Completion Date

May 3, 2022

Study Completion Date

May 3, 2022

Conditions
Cardiac SurgeryDexmedetomidineLong-term OutcomeMortalityQuality of Life
Interventions
DRUG

dexmedetomidine hydrochloride for injection

"Before anesthesia, dexmedetomidine hydrochloride for injection (200 ug/2 ml) will be diluted with normal saline to 50 ml (final dexmedetomidine concentration 4 ug/ml).~Before anesthesia induction, a loading dose will be administered by intravenous infusion at a rate of \[0.9\*kg\] ml/h for 10 minutes (i.e., dexmedetomidine 0.6 ug/kg in 10 minutes), followed by continuous infusion at a rate of \[0.1\*kg\] ml/h (i.e., dexmedetomidine at a rate of 0.4 ug/kg/h) until the end of surgery.~After surgery, the infusion rate will be decreased to \[0.025\*kg\] ml/h (i.e., dexmedetomidine at a rate of 0.1 ug/kg/h) and continued until the end of mechanical ventilation."

DRUG

0.9% sodium chloride for injection

"Before anesthesia, 0.9% sodium chloride for injection 50 ml will be prepared.~Before anesthesia induction, a loading dose will be administered by intravenous infusion at a rate of \[0.9\*kg\] ml/h for 10 minutes, followed by continuous infusion at a rate of \[0.1\*kg\] ml/h until the end of surgery.~After surgery, the infusion rate will be decreased to \[0.025\*kg\] ml/h and continued until the end of mechanical ventilation."

Trial Locations (2)

100034

Peking University First Hospital, Beijing

100037

Beijing Fuwai Hospital, Beijing

All Listed Sponsors
collaborator

Chinese Academy of Medical Sciences, Fuwai Hospital

OTHER

lead

Peking University First Hospital

OTHER

NCT03289325 - Dexmedetomidine and Long-term Outcomes in Elderly Patients After Cardiac Surgery | Biotech Hunter | Biotech Hunter